Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/16/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Fred Eshelman?

Fred N. Eshelman

Chief Executive Officer

PPD Inc

HQ Phone:  (910) 251-0081

Direct Phone: (910) ***-****direct phone

Email: f***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

PPD Inc

929 North Front Street

Wilmington, North Carolina,28401

United States

Company Description

PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices ...more

Background Information

Employment History

Chancellor

University of California , San Diego


Chancellor

North Carolina State University


Chancellor

University Professor Of Chemistry


Affiliations

Auven Therapeutics

Advisory Board Member


Eshelman Ventures LLC

Founder


GlaxoSmithKline plc

Senior Vice President, Development and Member of the Board of Directors


The Medical Foundation of North Carolina Inc

Executive Committee


G1 Therapeutics, Inc.

Board Member


Debt

Steering Committee Member


University of North Carolina

Board of Trustees


The Medicines Company

Board Member


Valeant Pharmaceuticals International

Board Member


Innocrin Pharmaceuticals Inc

Board Member


Neoantigenics Inc

Board Member


Medikidz Limited

Board Member


Cellective BioTherapy Inc

Board Member


Aero MD

Board Member


Eyenovia , Inc.

Board Member


Meryx , Inc.

Board Member


Dignify Therapeutic , Inc.

Board Member


Non-Employee

Board Member


Targanta Therapeutics Corp.

Board Member


InvestCorrectly

Board Member


Carolina Business Coalition

Board Member


Princeton BioPharma Capital Partners LLC

Business Advisory Board Member


Association of Clinical Research Organizations

Board Member


Celtic Therapeutics

Advisory Board Member


Wilmington Chamber of Commerce

Board Member


Visitors

Member of the Pharmacy School's Board


Cellona Therapeutics

Advisory Board Member


Accelerator Corporation

Board Member


University of Cincinnati

Faculty Member


N.C. Medical Foundation

Executive Committee


Computer Solutions

Board Member


Aton Pharma , Inc.

Board Member


School of Ph..

Member


Princeton Pharma Holdings LLC.

Member, Board


Catalytix Inc

Board of Advisors Member


Oriel Therapeutics Inc.

Board Member


Spotlight Health Inc

Board Member


PRIMECYTE , Inc.

Board Member


PPGx

Board Member


Board of Visitors

Member


Gov. Beverly Perdue

Board of Trustees


Can.Board Listed/Public CompaniesThe Medicines Company

Board Member


SARCO , Inc.

Chair, Board of Directors


Pharm

Founder


Education

B.S.

Harvard Business School


B.S.

pharmacy

University of North Carolina at Chapel Hill. He


BSc

pharmacy

UNC-CH


BSc

pharmacy

University of North Carolina , Chapel Hill


Graduate of the Owner/President Management program

Harvard Business School


Ph.D.

University of North Carolina-Chapel Hill


Pharm.D.

The School of Pharmacy at UNC Chapel Hill


bachelor's degree

High Point University


bachelor's degree

pharmacy

Carolina


bachelor's degree

pharmacy

UNC Chapel Hill


doctorate

pharmacy

University of Cincinnati


Web References(183 Total References)


Board of Directors - G1 Therapeutics

www.g1therapeutics.com [cached]

Fred Eshelman, PharmD
Fred Eshelman is the founder and principle of Eshelman Ventures LLC, investing in a variety of companies, primarily health care. Prior to that, he was the founding chairman of Furiex Pharmaceuticals (FURX, NASDAQ); the company was sold to Forest Labs/Actavis in July, 2014. Previously, he founded and served as CEO and Executive Chairman for Pharmaceutical Product Development, Inc. (PPDI, NASDAQ) until sale of the company to private equity interests (Carlyle, Hellman & Friedman). His career has also included positions as Senior Vice President, Development and board member at Glaxo Inc., as well as various management positions at Beecham Laboratories and Boehringer Mannheim Pharmaceuticals. He serves on a number of of industry boards. Eshelman has served on the executive committee of the Medical Foundation of North Carolina and the board of the NC Biotechnology Center. He is active in higher education, serving on the Board of Governors for the UNC System (chaired Audit Committee) and as an adjunct professor at the UNC School of Pharmacy, where he chairs the Board of Visitors. One of the top pharmacy programs in the US, in May 2008 the school was named the Eshelman School of Pharmacy, in recognition of his many contributions to the school and profession. He has received many awards, including the Davie and Outstanding Service awards from UNC-Chapel Hill and outstanding alumnus awards from UNC and University of Cincinnati schools of pharmacy. He has also received the Ernst & Young Entrepreneur of the Year and the NC Entrepreneur Hall of Fame Award. Dr. Eshelman holds a BSc pharmacy from UNC-CH, a doctor of pharmacy from the University of Cincinnati and completed a hospital residency at Cincinnati General Hospital. He completed the Owner/President/Manager program at Harvard Business School.


Board of Directors - G1 Therapeutics

www.g1therapeutics.com [cached]

Fred Eshelman, PharmD
Fred Eshelman is the founder and principle of Eshelman Ventures LLC, investing in a variety of companies, primarily health care. Prior to that, he was the founding chairman of Furiex Pharmaceuticals (FURX, NASDAQ); the company was sold to Forest Labs/Actavis in July, 2014. Previously, he founded and served as CEO and Executive Chairman for Pharmaceutical Product Development, Inc. (PPDI, NASDAQ) until sale of the company to private equity interests (Carlyle, Hellman & Friedman). His career has also included positions as Senior Vice President, Development and board member at Glaxo Inc., as well as various management positions at Beecham Laboratories and Boehringer Mannheim Pharmaceuticals. He serves on a number of of industry boards. Eshelman has served on the executive committee of the Medical Foundation of North Carolina and the board of the NC Biotechnology Center. He is active in higher education, serving on the Board of Governors for the UNC System (chaired Audit Committee) and as an adjunct professor at the UNC School of Pharmacy, where he chairs the Board of Visitors. One of the top pharmacy programs in the US, in May 2008 the school was named the Eshelman School of Pharmacy, in recognition of his many contributions to the school and profession. He has received many awards, including the Davie and Outstanding Service awards from UNC-Chapel Hill and outstanding alumnus awards from UNC and University of Cincinnati schools of pharmacy. He has also received the Ernst & Young Entrepreneur of the Year and the NC Entrepreneur Hall of Fame Award. Dr. Eshelman holds a BSc pharmacy from UNC-CH, a doctor of pharmacy from the University of Cincinnati and completed a hospital residency at Cincinnati General Hospital. He completed the Owner/President/Manager program at Harvard Business School.


Board of Directors | The Medicines Company

www.themedicinescompany.com [cached]

Fredric N. Eshelman, Pharm.D
Non-Executive Chairman, Member of Audit Committee Fredric N. Eshelman has been a director and chairman since August 2015. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. Dr. Eshelman was the founder of Pharmaceutical Product Development, Inc. (PPD) and founding chairman of Furiex Pharmaceuticals, Inc. In 2014, Dr. Eshelman founded Eshelman Ventures, LLC, an investment company focused on healthcare companies. From 2009 to 2014, Dr. Eshelman served as Chairman of the Board of Furiex. From 2009 to 2011, he served as Executive Chairman of PPD. He also served as Chief Executive Officer of PPD from 1990 to 2009 and as Vice Chairman of its Board of Directors from 1993 to 2009. Dr. Eshelman currently serves on the board of directors of AeroMD, Cellective Biotherapy, Inc., Dignify Therapeutic, Inc., Eyenovia, Inc., G1 Therapeutics, Inc., Innocrin Pharmaceuticals, Inc., Medikidz USA, Inc., Meryx, Inc. and Neoantigenics LLC and Valeant Pharmaceuticals International, Inc., and the advisory board of Auven Therapeutics. Dr. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. Dr. Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award. He has received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He is a graduate of the OPM program at Harvard Business School.


Board of Directors | The Medicines Company

profibrix.com [cached]

Fredric N. Eshelman, Pharm.D
Non-Executive Chairman Fredric N. Eshelman has been a director and chairman since August 2015. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. Dr. Eshelman was the founder of Pharmaceutical Product Development, Inc. (PPD) and founding chairman of Furiex Pharmaceuticals, Inc. In 2014, Dr. Eshelman founded Eshelman Ventures, LLC, an investment company focused on healthcare companies. From 2009 to 2014, Dr. Eshelman served as Chairman of the Board of Furiex. From 2009 to 2011, he served as Executive Chairman of PPD. He also served as Chief Executive Officer of PPD from 1990 to 2009 and as Vice Chairman of its Board of Directors from 1993 to 2009. Dr. Eshelman currently serves on the board of directors of AeroMD, Cellective Biotherapy, Inc., Dignify Therapeutic, Inc., Eyenovia, Inc., G1 Therapeutics, Inc., Innocrin Pharmaceuticals, Inc., Medikidz USA, Inc., Meryx, Inc. and Neoantigenics LLC, and the advisory board of Auven Therapeutics. Dr. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. Dr. Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award. He has received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He is a graduate of the OPM program at Harvard Business School.


www.sec.gov

Dr. Frederic N. Eshelman
From July 2009 to July 2014, Dr. Eshelman served as the Chairman of Furiex Pharmaceuticals, Inc., a drug development company that collaborated with pharmaceutical and biotechnology companies to increase the value of their drug candidates by applying an accelerated approach to drug development. He was the founder and former CEO and Executive Chairman of Pharmaceutical Product Development, Inc., a global contract pharmaceutical research organization providing drug discovery, development and lifecycle management services from July 2009 to December 2011. Dr. Eshelman currently serves as Chairman of The Medicines Company. Director Qualifications: The Board has determined that Dr. Eshelman's experience as a CEO of a publicly-traded company, where he demonstrated leadership capability and extensive knowledge of the pharmaceutical industry and complex financial and operational matters facing large organizations and his breadth of experience in corporate governance qualify him to serve as a member of the Board and the committees on which he sits. Dr. Fredric N. Eshelman Dr. Eshelman has until March 2021 to achieve the expected minimum equity ownership under the share ownership guidelines. The 12 independent directors currently on the board are: Mr. Ross (Lead Independent Director), Mr. Ackman, Mr. DeSchutter, Dr. Eshelman, Mr. Fraidin, Mr. Hale, Mr. Ingram, Dr. Karabelas, Ms. Kavanagh, Mr. Power, Mr. Robertson and Dr. Wechsler.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory